The annual GRK2158 symposia serve as a perfect platform for a get-together of all participating doctoral researchers, principal investigators and external guests. The exchange of all GRK2158 members, the intensification of collaborations, but also the critical discussion of the results represent the main objectives of our symposia. Therefore, the doctoral researchers present the projects and results in talks or on posters followed by lively discussions among the GRK members, but also with the invited speakers who also give presentations about their research.
The annual symposium in 2022 will take place from 28th till 29th of November in House of University in Düsseldorf.
Confirmed speakers are:
George Burslem, University of Pennsylvania, USA
Isabelle Schalk, University of Stasbourg, France
Bernd Riedl, Bayer AG, Wuppertal, Germany
Andreas Strasser, Walter and Eliza Hall Institute of Medical Research, Australia
Roderich Süßmuth, TU Berlin, Germany
Click here for more information.
The presentations of the guest speakers from academia and industry were very impressive and thematically perfectly fitted the Research Training Group. We would like to thank Simone Moser (LMU Munich), Susanne Roehrig (Bayer Helathcare AG), Anna Hirsch (HIPS) and Jon Clardy (Harvard University, USA) for the insights into their very interesting research.
The presentations of the two PhD students, Laura Schmitt and Marco Kruppa, showed only a small part of the work taking place in the GRK, but reflected the excellent projects as well as the close cooperation of the members of the Research Training Group, which contribute significantly to the success of the GRK.
|Invited Speakers||Title of Talk|
Prof. Dr. Jon Clardy
Chasing Molecules and Mechanisms in the Human Gut Microbiome
Prof. Dr. Anna Hirsch
|Addressing unusual anti-infective targets|
Dr. Simone Moser
|Phyllobilins - Chlorophyll breakdown as source of bioactive compounds|
Dr. Susanne Roehrig
Medizinische Chemie, Bayer AG, Germany
Discovery and development of the novel antithrombotic agent rivaroxaban, an orally active, direct factor Xa inhibitor
Since we met online, we could only take a virtual group picture...
The annual GRK2158 symposium should have taken place in Sport+Seminarcenter Radevormwald from 16.-18.3.20. Due to Covid-19 the symposium was postponed to the 1st & 2nd of July and took place as an online event. Thanks to all people how helped to organized this event and thanks to all the speakers.
The program is now available here (PDF).
Additionally to the talks of the doctoral students of GRK2158 the highly interesting talks of the invited speakerscompleted the program perfectly.
|Invited Speaker||Title of Talk|
Prof. Dr. Uli Kazmaier
Insititute of Organic Chemistry, Saarland University
Stereoselective peptide modifications – versatile tools for natural product and drug synthesis
Prof. Dr. Julia Bandow
Applied Microbiology, Ruhr University Bochum
|Antibacterial strategies – from the discovery of new compound classes to antibiotic mechanism elucidation|
Dr. Sanil Bhatia
Department of Pediatric Oncology, Hematology and Clinical Immunology, HHU Düsseldorf
|Novel therapeutic strategies for resistant childhood acute lymphoblastic leukemia|
Some impressions of our online symposium....
From 27th until 28th of May 2019 all members of Research Group 2158 met at the "Haus der Universität" in Düsseldorf for the annual symposium. All doctoral students of GRK2158 contributed with highly professional talks or well prepared posters to a successful and productive symposium.
As a special highlight Prof. Dr. Dr. h.c. Peter Proksch who was the initiative speaker of GRK2158 gave a very intersting and vivid talk about his "Tales from Ecological Chemistry".
We were also happy to hear the talks of the invited speakers which completed the program in a perfect manner.
|Invited Speaker||Title of Talk|
Prof. Dr. Maria Chiara Monti
Univerista’ degli Studi di Salerno, Italy
|Proteomic approaches to disclose natural products cellular targets|
Prof. Dr. Christian Ottmann
Eindhoven University of Technology, Netherlands
|Natural-product stabilization of 14-3-3 protein-protein interactions|
Prof. Dr. Markus Kaiser
University of Duisburg-Essen, Germany
|Natural products in medicinal chemistry and chemical probe discovery|
Prof. Dr. Tanja Schneider
University of Bonn, Germany
|Targeting a cell wall biosynthesis hot spot|
More information about the program you can find here: GRK2158 Symposium 2019 program
The long-standing cooperation between the Institute of Pharmaceutical Biology of the University of Duesseldorf and State Key Laboratoty of Natural and Biomimetic Drugs of Peking University is not only a basis for a fruitful exchange of knowledge about natural products and new natural products themselves, but has now led to the joint organization of this year's symposium about “Natural products and analogs against therapy resistant tumours and microorganisms” from Sept 17 till 21 in Beijing, China.
Together with Prof. Dr Wenhan Lin, who is participated in GRK2158 as a Mercator fellow, GRK2158 provided an excellent platform for all German and Chinese doctoral students and principal investigators for presenting and discussing their research concerning natural products as well as for the establishing of new research cooperations.
50 participants from Heinrich Heine University and Chinese Universities and Research institutes met at the Conference Center of Medical Health Center of Peking University and discuss their research on Natural compounds and analogs against therapy resistant tumours and microorganisms.
The program and all abstracts are available in the Abstractbooklet (PDF).
In 2017 we met at the Meeting and Guest House of HHU, Schloß Mickeln, from September 20-22. All doctoral researchers presented their projects in talk and on a poster in a very professional and confident manner. The symposium was wonderfully completed by the talks of our Mercator fellow Prof. Dr. Wenhan Lin form Peking University, China, and our external guests Dr. Min-Li Weber from German Cancer Research Centre in Heidelberg and Prof. Dr. Mark Brönstrup from Helmholtz Centre for Infection Research in Braunschweig.
|Prof. Dr. Wenhan Lin, Peking University, China||Antivirus molecules derived from marine organisms|
|Dr. Min-Li Weber, German Cancer Research Centre Heidelberg||Overcome resistance in cancer by the phytochemicals rocaglamides|
|Prof. Dr. Marc Brönstrup, Helmholtz Centre for Infection Research Braunschweig||Chemical Biology Directed to Antiinfective Drug Discovery|